Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
The reversibility of mitotic exit in vertebrate cells.
Potapova TA, Daum JR, Pittman BD, Hudson JR, Jones TN, Satinover DL, Stukenberg PT, Gorbsky GJ.
???displayArticle.abstract???
A guiding hypothesis for cell-cycle regulation asserts that regulated proteolysis constrains the directionality of certain cell-cycle transitions. Here we test this hypothesis for mitotic exit, which is regulated by degradation of the cyclin-dependent kinase 1 (Cdk1) activator, cyclin B. Application of chemical Cdk1 inhibitors to cells in mitosis induces cytokinesis and other normal aspects of mitotic exit, including cyclin B degradation. However, chromatid segregation fails, resulting in entrapment of chromatin in the midbody. If cyclin B degradation is blocked with a proteasome inhibitor or by expression of non-degradable cyclin B, Cdk inhibitors will nonetheless induce mitotic exit and cytokinesis. However, if after mitotic exit, the Cdk1 inhibitor is washed free from cells in which cyclin B degradation is blocked, the cells can revert back to M phase. This reversal is characterized by chromosome recondensation, nuclear envelope breakdown, assembly of microtubules into a mitotic spindle, and in most cases, dissolution of the midbody, reopening of the cleavage furrow, and realignment of chromosomes at the metaphase plate. These findings demonstrate that proteasome-dependent degradation of cyclin B provides directionality for the M phase to G1 transition.
Carmena,
The cellular geography of aurora kinases.
2003, Pubmed,
Xenbase
Carmena,
The cellular geography of aurora kinases.
2003,
Pubmed
,
Xenbase Chang,
Degradation of cyclin B is required for the onset of anaphase in Mammalian cells.
2003,
Pubmed Clute,
Temporal and spatial control of cyclin B1 destruction in metaphase.
1999,
Pubmed Cross,
Quantitative characterization of a mitotic cyclin threshold regulating exit from mitosis.
2005,
Pubmed
,
Xenbase den Elzen,
Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase.
2001,
Pubmed Dranovsky,
Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology.
2001,
Pubmed Evans,
Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division.
1983,
Pubmed Geley,
Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint.
2001,
Pubmed Glotzer,
The molecular requirements for cytokinesis.
2005,
Pubmed Glotzer,
Cyclin is degraded by the ubiquitin pathway.
1991,
Pubmed
,
Xenbase Kramer,
Mitotic regulation of the APC activator proteins CDC20 and CDH1.
2000,
Pubmed
,
Xenbase Losiewicz,
Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275.
1994,
Pubmed Minshull,
The role of cyclin synthesis, modification and destruction in the control of cell division.
1989,
Pubmed
,
Xenbase Mishima,
Cell cycle regulation of central spindle assembly.
2004,
Pubmed Murray,
Cyclin synthesis drives the early embryonic cell cycle.
1989,
Pubmed
,
Xenbase Niiya,
Inhibition of cyclin-dependent kinase 1 induces cytokinesis without chromosome segregation in an ECT2 and MgcRacGAP-dependent manner.
2005,
Pubmed Parry,
The schedule of destruction of three mitotic cyclins can dictate the timing of events during exit from mitosis.
2001,
Pubmed
,
Xenbase Pomerening,
Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2.
2003,
Pubmed
,
Xenbase Reed,
Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover.
2003,
Pubmed Sha,
Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts.
2003,
Pubmed
,
Xenbase Sigrist,
Exit from mitosis is regulated by Drosophila fizzy and the sequential destruction of cyclins A, B and B3.
1995,
Pubmed Visintin,
The phosphatase Cdc14 triggers mitotic exit by reversal of Cdk-dependent phosphorylation.
1998,
Pubmed
